1/49
A set of 50 vocabulary flashcards covering basic immunology, autoimmune diseases, antinuclear antibodies, genetics, molecular diagnostics, and precision oncology.
Primary Lymphoid Organs
Sites where lymphocytes develop, specifically the bone marrow for B cells and the thymus for T cells.
Secondary Lymphoid Organs
Sites where immune responses are initiated and maintained, including the lymph nodes, spleen, and mucosal-associated lymphoid tissue (MALT).
Affinity
The attractive force between a single epitope and an antibody binding site.
Avidity
The sum of total attractive forces between a multivalent antigen and an antibody.
Fab Region
The variable region of an antibody responsible for highly specific antigen binding.
Fc Region
The constant region of an antibody responsible for immune effector functions.
Neutralization
An antibody effector mechanism that eliminates pathogens by preventing adherence.
Opsonization
An antibody effector mechanism that enhances pathogen phagocytosis via Fc receptors.

IgG Molecule Structure
A 150kDa immunoglobulin structure comprising paired heavy and light chain domains divided into Fab, Fv, and Fc functional regions.
Correlate of Protection
Vaccine-induced binding antibodies against the viral spike protein whose titer levels can predict protection from infection.
Synthetic Monoclonal Antibody Therapies
Therapies targeting specific conserved epitopes on the SARS-CoV-2 spike protein receptor-binding domain (RBD).
Type I Hypersensitivity
An immediate, anaphylactic/allergic reaction mediated by IgE binding to soluble antigens on mast cells and basophils.
Type II Hypersensitivity
An immediate reaction involving IgG or IgM targeting cell-surface antigens or receptors, leading to complement activation or phagocytosis.
Type III Hypersensitivity
An immune complex-mediated reaction driven by IgG or IgM complexes formed with soluble antigens that deposit in tissues and activate complement or phagocytes.
Type IV Hypersensitivity
A delayed reaction (24–72hours) mediated by T cells (Th1, Th2, CTL) and macrophages without antibodies.
Innate Immunity
Immune defense that acts within minutes to hours, recognizes shared structural patterns, possesses limited diversity, and generally lacks immunological memory.
Adaptive Immunity
Antigen-specific immune defense that takes days to respond, possesses an extremely large diversity (1018), and exhibits robust immunological memory.
B Cells
Lymphocytes that originate and develop in the bone marrow, recognize antigens via B-cell receptors, and function in antibody production, antigen presentation, neutralization, opsonization, and complement activation.
T Cells
Lymphocytes that originate in the bone marrow, develop in the thymus, recognize peptide antigens presented via MHC molecules using T-cell receptors, and function in cell killing and cytokine secretion.
Hypergammaglobulinemia
An elevation of immunoglobulins that can be polyclonal (reactive to infection or inflammation) or monoclonal (resulting from a clonal expansion of plasma cells or B cells).
Multiple Myeloma
A plasma cell neoplasm that can progress from non-IgM MGUS, diagnosed and confirmed via serum protein electrophoresis (SPEP) and immunofixation.
CRAB Mnemonic
A clinical summary of end-organ damage in multiple myeloma: Hypercalcemia (C), Renal dysfunction (R), Anemia (A), and Lytic bone lesions / bone pain (B).
Waldenström's Macroglobulinemia
An indolent lymphoplasmacytic lymphoma characterized by overproduction of monoclonal pentameric IgM, causing hyperviscosity syndrome.
Clonal Deletion
The elimination of immature lymphocytes expressing self-reactive receptors via apoptosis in primary lymphoid organs to prevent autoimmunity.
Rheumatoid Factors (RF)
Autoantibodies targeting the constant (Fc) region of IgG, present in 70–80% of rheumatoid arthritis patients but possessing low diagnostic specificity.
Anti-Citrullinated Protein Antibodies (anti-CCP / ACPA)
Autoantibodies directed against citrullinated proteins that exhibit high diagnostic specificity (>90%) for rheumatoid arthritis.
Indirect Immunofluorescence Assay (IIFA)
The established gold standard screening technique for ANA detection utilizing HEp-2 cells and fluoresceinated anti-IgG antibodies visualized under a fluorescence microscope.
Homogeneous ANA Pattern
A nuclear staining pattern associated with systemic lupus erythematosus (SLE) and drug-induced lupus that targets dsDNA, histones, and nucleosomes.
Speckled ANA Pattern
An ANA staining pattern associated with SLE, systemic sclerosis, Sjögren's syndrome, MCTD, and inflammatory myopathies that targets extractable nuclear antigens (Sm, RNP, Ro/SSA, La/SSB).
Nucleolar ANA Pattern
An ANA staining pattern associated with systemic sclerosis and SLE that targets nucleolar components and Scl-70.
Peripheral (Rim) ANA Pattern
An ANA staining pattern targeting dsDNA that is highly associated with systemic lupus erythematosus (SLE).
Centromere ANA Pattern
An ANA staining pattern targeting centromeric proteins (CENP-A, B, C, D) that is highly associated with CREST syndrome (limited scleroderma).
ANA Titer
The highest serial dilution of patient serum that still yields a positive fluorescence signal, providing semi-quantitative information on autoantibody levels.
Protein-Coding Genes
Sequences that make up approximately 1.5% of the human genome, with the remaining majority consisting of non-coding regions and repetitive elements.
Central Dogma
The biological principle describing the flow of genetic information within a biological system from DNA→mRNA→Protein.
DNA Replication
The synthesis of a complete DNA copy of an entire chromosome for cell division via mitosis or meiosis.
RNA Transcription
The process of copying a specific section of DNA into single-stranded RNA, including pre-mRNA splicing to remove introns and addition of a protective cap and tail.
RNA Translation
The ribosomal process of translating an mRNA sequence into an amino acid chain, where unique R-groups dictate structure and function.
Carrier Genetic Testing
Testing performed on asymptomatic individuals for recessive conditions to understand reproductive risks.
Presymptomatic Genetic Testing
Genetic testing performed to detect variants associated with genetic conditions before symptoms start to manifest.
Pharmacogenetic Testing
Genetic testing assessing how an individual's genetic profile impacts drug metabolism and response.
Genetic Information Nondiscrimination Act (GINA)
Legislation protecting individuals from genetic discrimination in employment and health coverage, but not applying to life insurance, disability insurance, or the military.
Bacterial Genome
A singular circular chromosome (3–6Mb) containing 4,000–5,000 genes and self-replicating extrachromosomal plasmids.
Antigenic Drift
Gradual changes in viral antigens caused by high mutation frequencies when viruses hijack host cell machinery to replicate.
Antigenic Shift
Major alterations resulting from genomic segment reassortment when host cells are co-infected by different viruses.
Pathogen-Specific Assays
Assays that target a unique, organism-specific nucleic acid sequence with high sensitivity to detect a single pathogen.
Broad-Range Assays
Assays targeting a polymorphic gene sequence shared across a class of organisms combined with DNA sequencing to identify unknown or unexpected pathogens.
Metagenomic Approaches
Unbiased sequencing of all DNA in a patient specimen using massive read counts to identify bacteria, viruses, or parasites.
Pathogen Load Assays
Quantitative assays (such as quantitative RT-PCR or ddPCR) that measure amounts of a pathogen over time to monitor treatment response.
Biomarker
A measurable biological clue about a cancer—such as a specific gene mutation, fusion, copy-number change, or protein level—used to guide targeted clinical care.